Program overview
Context
Indication: Relapsed / Refractory Mantle Cell Lymphoma (MCL)
Mechanism: Unknown
Modality: Unknown
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., .
TQ-B3525 is flagged as timeline staleness signal because public records show timeline staleness. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Relapsed / Refractory Mantle Cell Lymphoma (MCL)
Mechanism: Unknown
Modality: Unknown
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., .
Registry: 3/5
Timeline: 3/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 3/5
https://clinicaltrials.gov/study/NCT04398953
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT04398953 | Unknown Status Signal (UNKNOWN) | stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal | Low Signal | None |